Angiogenesis Inhibition

  • Rüdiger Liersch
  • Wolfgang E. Berdel
  • Torsten Kessler

Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 180)

Table of contents

  1. Front Matter
    Pages i-xiv
  2. Rüdiger Liersch, Wolfgang E. Berdel, Torsten Kessler
    Pages 1-1
  3. Yvonne Reiss
    Pages 3-13
  4. Mei Yee Koh, Taly R. Spivak-Kroizman, Garth Powis
    Pages 15-34
  5. Andreas Hippe, Bernhard Homey, Anja Mueller-Homey
    Pages 35-50
  6. Iris Appelmann, Rüediger Liersch, Torsten Kessler, Rolf M. Mesters, Wolfgang E. Berdel
    Pages 51-81
  7. Curzio Rüegg, Gian Carlo Alghisi
    Pages 83-101
  8. Carina Hellberg, Arne Östman, C.-H. Heldin
    Pages 103-114
  9. Rüediger Liersch, Christoph Biermann, Rolf M. Mesters, Wolfgang E. Berdel
    Pages 115-135
  10. Torsten Kessler, Michael Bayer, Christian Schwöppe, Rüdiger Liersch, Rolf M. Mesters, Wolfgang E. Berdel
    Pages 137-163
  11. Urban Emmenegger, Giulio Francia, Yuval Shaked, Robert S. Kerbel
    Pages 165-183
  12. Hans-Peter Gerber, Ezogelin Olazoglu, Iqbal S. Grewal
    Pages 185-200
  13. Christoph Schliemann, Dario Neri
    Pages 201-216
  14. Kerri A. Massey, Jan E. Schnitzer
    Pages 217-231

About this book

Introduction

Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies.

This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials on therapeutic compounds are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in research and treatment in this exciting field.

Keywords

Cancer treatment Lymphangiogenesis Vascular targeting angiogenesis imaging

Editors and affiliations

  • Rüdiger Liersch
    • 1
  • Wolfgang E. Berdel
    • 2
  • Torsten Kessler
    • 3
  1. 1.Medizinische Klinik und Poliklinik AUniversitätsklinikum MünsterMünsterGermany
  2. 2.Medizinische Klinik und PoliklinikUniversitätsklinikum MünsterMünsterGermany
  3. 3.Medizinische Klinik und Poliklinik AUniversitätsklinikum MünsterMünsterGermany

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-540-78281-0
  • Copyright Information Springer-Verlag Berlin Heidelberg 2010
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Medicine
  • Print ISBN 978-3-540-78280-3
  • Online ISBN 978-3-540-78281-0
  • Series Print ISSN 0080-0015
  • About this book
Industry Sectors
Biotechnology
Pharma